# OptimizeRx Corp: Form 8-K, filed Mar 30, 2026

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: 8-K
- Filed: 2026-03-30
- Accepted by EDGAR: Mar 30, 2026, 21:29 ET
- Period: 2026-03-24
- Accession: 0001448431-26-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000007/oprx-20260324.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000007/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000144843126000007/oprx-20260324.htm

Filed Mar 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001448431-26-000007. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.